Parallel Bio develops groundbreaking approaches in drug discovery by focusing on the human immune system. The company has created an innovative platform that replicates the human immune system in vitro, enabling the rapid identification and development of new drugs and immunotherapies that are more likely to succeed in patients. With a mission to significantly reduce the historically high drug failure rate, Parallel Bio aims to transform the biopharmaceutical landscape by designing and engineering tools inspired by human biology, moving beyond traditional animal models and synthetic systems. The company's values emphasize collaboration, first-principles thinking, and a passion for scientific excellence, fostering a diverse and dynamic workplace where innovation thrives and every team member plays a vital role in reshaping the future of medicine.